Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology

PLoS Pathogens

Volumn 8, Issue 8, 2012, Pages

  Köser, Claudio U ^a,b   Ellington, Matthew J ^b   Cartwright, Edward J P ^a,b   Gillespie, Stephen H ^c   Brown, Nicholas M ^b   Farrington, Mark ^b   Holden, Matthew T G ^d   Dougan, Gordon ^d   Bentley, Stephen D ^d   Parkhill, Julian ^d   Peacock, Sharon J ^a,b,d,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BORDETELLA PERTUSSIS; DNA SEQUENCE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FUNGAL DETECTION; GENE SEQUENCE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL GENETICS; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; VANCOMYCIN RESISTANT ENTEROCOCCUS; WHOLE GENOME SEQUENCING;

BACTERIA; BACTERIAL INFECTIONS; DNA, BACTERIAL; GENOME, BACTERIAL; HUMANS; SEQUENCE ANALYSIS, DNA;

EID: 84866148001     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002824     Document Type: Article

References (118)

1. Venter JC, (2010) Multiple personal genomes await. Nature 464: 676-677.
2. Lander ES, (2011) Initial impact of the sequencing of the human genome. Nature 470: 187-197.
3. Loman NJ, Pallen MJ, (2008) XDR-TB genome sequencing: a glimpse of the microbiology of the future. Future Microbiol 3: 111-113.
4. Baldry S, (2010) Attack of the clones. Nat Rev Microbiol 8: 390.
5. Cartwright EJ, Köser CU, Peacock SJ, (2011) Microbial sequences benefit health now. Nature 471: 578.
6. Otto TD, (2011) Real-time sequencing. Nat Rev Microbiol 9: 633.
7. Infectious Diseases Society of America (2010) The 10×'20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 50: 1081-1083.
8. Gega A, Kozal MJ, (2011) New technology to detect low-level drug-resistant HIV variants. Future Virol 6: 17-26.
9. Niedringhaus TP, Milanova D, Kerby MB, Snyder MP, Barron AE, (2011) Landscape of next-generation sequencing technologies. Anal Chem 83: 4327-4341.
10. Eisen JA, MacCallum CJ, (2009) Genomics of emerging infectious disease: a PLoS collection. PLoS Biol 7: e1000224 doi:10.1371/journal.pbio.1000224.
11. MacLean D, Jones JDG, Studholme DJ, (2009) Application of 'next-generation' sequencing technologies to microbial genetics. Nat Rev Microbiol 7: 287-296.
12. Pallen MJ, Loman NJ, Penn CW, (2010) High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. Curr Opin Microbiol 13: 625-631.
13. Brockhurst MA, Colegrave N, Rozen DE, (2011) Next-generation sequencing as a tool to study microbial evolution. Mol Ecol 20: 972-980.
14. Fournier PE, Drancourt M, Raoult D, (2007) Bacterial genome sequencing and its use in infectious diseases. Lancet Infect Dis 7: 711-723.
15. Parkhill J, Wren BW, (2011) Bacterial epidemiology and biology-lessons from genome sequencing. Genome Biol 12: 230.
16. Relman DA, (2011) Microbial genomics and infectious diseases. N Engl J Med 365: 347-357.
17. Achtman M, (2012) Insights from genomic comparisons of genetically monomorphic bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 367: 860-867.
18. Olsen RJ, Long SW, Musser JM, (2012) Bacterial genomics in infectious disease and the clinical pathology laboratory. Arch Pathol Lab Med.
19. Dumitrescu O, Dauwalder O, Lina G, (2011) Present and future automation in bacteriology. Clin Microbiol Infect 17: 649-650.
20. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G, (2010) Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 48: 1549-1554.
21. Neville SA, Lecordier A, Ziochos H, Chater MJ, Gosbell IB, et al. (2011) Utility of matrix-assisted laser desorption ionization-time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J Clin Microbiol 49: 2980-2984.
22. Wieser A, Schneider L, Jung J, Schubert S, (2012) MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Appl Microbiol Biotechnol 93: 965-974.
23. Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, et al. (2012) Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 366: 2267-2275.
24. Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, et al. (2010) Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 65: 446-448.
25. Schürch AC, Siezen RJ, (2010) Genomic tracing of epidemics and disease outbreaks. Microb Biotechnol 3: 628-633.
26. Rasko DA, Worsham PL, Abshire TG, Stanley ST, Bannan JD, et al. (2011) Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation. Proc Natl Acad Sci U S A 108: 5027-5032.
27. Grad YH, Lipsitch M, Feldgarden M, Arachchi HM, Cerqueira GC, et al. (2012) Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci U S A 109: 3065-3070.
28. Niemann S, Köser CU, Gagneux S, Plinke C, Homolka S, et al. (2009) Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLoS One 4: e7407 doi:10.1371/journal.pone.0007407.
29. Beres SB, Carroll RK, Shea PR, Sitkiewicz I, Martinez-Gutierrez JC, et al. (2010) Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci U S A 107: 4371-4376.
30. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, et al. (2010) Evolution of MRSA during hospital transmission and intercontinental spread. Science 327: 469-474.
31. Schürch AC, Kremer K, Kiers A, Daviena O, Boeree MJ, et al. (2010) The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale. Infect Genet Evol 10: 108-114.
32. Schürch AC, Kremer K, Daviena O, Kiers A, Boeree MJ, et al. (2010) High-resolution typing by integration of genome sequencing data in a large tuberculosis cluster. J Clin Microbiol 48: 3403-3406.
33. Brzuszkiewicz E, Thurmer A, Schuldes J, Leimbach A, Liesegang H, et al. (2011) Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol 193: 883-891.
34. Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, et al. (2011) The origin of the Haitian cholera outbreak strain. N Engl J Med 364: 33-42.
35. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, et al. (2011) Rapid pneumococcal evolution in response to clinical interventions. Science 331: 430-434.
36. Eppinger M, Mammel MK, Leclerc JE, Ravel J, Cebula TA, (2011) Genomic anatomy of Escherichia coli O157:H7 outbreaks. Proc Natl Acad Sci U S A 108: 20142-20147.
37. Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, et al. (2011) Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364: 730-739.
38. Lienau EK, Strain E, Wang C, Zheng J, Ottesen AR, et al. (2011) Identification of a salmonellosis outbreak by means of molecular sequencing. N Engl J Med 364: 981-982.
39. Hendriksen RS, Price LB, Schupp JM, Gillece JD, Kaas RS, et al. (2011) Population genetics of Vibrio cholerae from Nepal in 2010: evidence on the origin of the Haitian outbreak. MBio 2: e00157-e00111.
40. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, et al. (2011) Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PloS One 6: e22751 doi:10.1371/journal.pone.0022751.
41. Mutreja A, Kim DW, Thomson NR, Connor TR, Lee JH, et al. (2011) Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477: 462-465.
42. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, et al. (2011) Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 365: 709-717.
43. Rohde H, Qin J, Cui Y, Li D, Loman NJ, et al. (2011) Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N Engl J Med 365: 718-724.
44. Truman RW, Singh P, Sharma R, Busso P, Rougemont J, et al. (2011) Probable zoonotic leprosy in the southern United States. N Engl J Med 364: 1626-1633.
45. Alexander DC, Hao W, Gilmour MW, Zittermann S, Sarabia A, et al. (2012) Escherichia coli O104:H4 infections and international travel. Emerg Infect Dis 18: 473-476.
46. Allard MW, Luo Y, Strain E, Li C, Keys CE, et al. (2012) High resolution clustering of Salmonella enterica serovar Montevideo strains using a next-generation sequencing approach. BMC Genomics 13: 32.
47. Fittipaldi N, Beres SB, Olsen RJ, Kapur V, Shea PR, et al. (2012) Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group a Streptococcus. Am J Pathol 180: 1522-1534.
48. Harris SR, Clarke IN, Seth-Smith HM, Solomon AW, Cutcliffe LT, et al. (2012) Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet 44: 413-419.
49. Hasan NA, Choi SY, Eppinger M, Clark PW, Chen A, et al. (2012) Genomic diversity of 2010 Haitian cholera outbreak strains. Proc Natl Acad Sci U S A.
50. Okoro CK, Kingsley RA, Quail MA, Kankwatira AM, Feasey NA, et al. (2012) High-resolution single nucleotide polymorphism analysis distinguishes recrudescence and reinfection in recurrent invasive nontyphoidal Salmonella typhimurium disease. Clin Infect Dis 54: 955-963.
51. Andersen BM, Tollefsen T, Seljordslia B, Hochlin K, Syversen G, et al. (2010) Rapid MRSA test in exposed persons: costs and savings in hospitals. J Infect 60: 293-299.
52. Dolgin E, (2010) Sequencing of superbugs seen as key to combating their spread. Nat Med 16: 1054.
53. Lewis T, Loman NJ, Bingle L, Jumaa P, Weinstock GM, et al. (2010) High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 75: 37-41.
54. Engelthaler DM, Chiller T, Schupp JA, Colvin J, Beckstrom-Sternberg SM, et al. (2011) Next-generation sequencing of Coccidioides immitis isolated during cluster investigation. Emerg Infect Dis 17: 227-232.
55. Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, et al. (2011) Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet 43: 1275-1280.
56. Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, et al. (2012) A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2.
57. McAdam PR, Templeton KE, Edwards GF, Holden MT, Feil EJ, et al. (2012) Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 109: 9107-9112.
58. Human Genomics Strategy Group (2012) Building on our inheritance. Genomic technology in healthcare. United Kingdom: Department of Health.
59. Achtman M, (2008) Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu Rev Microbiol 62: 53-70.
60. Parrish N, Carrol K, (2008) Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis. Future Microbiol 3: 405-413.
61. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
62. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W, (2010) Xpert MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn 10: 937-946.
63. Schürch AC, van Soolingen D, (2012) DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect Genet Evol 12: 602-609.
64. Schindele B, Apelt L, Hofmann J, Nitsche A, Michel D, et al. (2010) Improved detection of mutated human cytomegalovirus UL97 by pyrosequencing. Antimicrob Agents Chemother 54: 5234-5241.
65. Wright CF, Morelli MJ, Thébaud G, Knowles NJ, Herzyk P, et al. (2011) Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. J Virol 85: 2266-2275.
66. Vandekerckhove L, Wensing A, Kaiser R, Brun-Vézinet F, Clotet B, et al. (2011) European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis 11: 394-407.
67. Daumer M, Kaiser R, Klein R, Lengauer T, Thiele B, et al. (2011) Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis. BMC Med Inform Decis Mak 11: 30.
68. Saliou A, Delobel P, Dubois M, Nicot F, Raymond S, et al. (2011) Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism. Antimicrob Agents Chemother 55: 2831-2836.
69. Swenson LC, Mo T, Dong WW, Zhong X, Woods CK, et al. (2011) Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. J Infect Dis 203: 237-245.
70. Gianella S, Richman DD, (2010) Minority variants of drug-resistant HIV. J Infect Dis 202: 657-666.
71. Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, et al. (2011) Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. JAMA 305: 1327-1335.
72. Kuritzkes DR, Grant RM, Feorino P, Griswold M, Hoover M, et al. (2003) Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System. J Clin Microbiol 41: 1594-1599.
73. GenomeWeb (2011) Illumina, Siemens forge deal to make HIV test compatible with MiSeq. Available: http://www.genomeweb.com/sequencing/illumina-siemens-forge-deal-make-hiv-test-compatible-miseq.
74. Pallen MJ, Loman NJ, (2011) Are diagnostic and public health bacteriology ready to become branches of genomic medicine? Genome Med 3: 53.
75. Pathogenica (2011) Technology. Pathogenica website. Available: http://www.pathogenica.com/technology.php.
76. Tucker T, Marra M, Friedman JM, (2009) Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet 85: 142-154.
77. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, et al. (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120: 4332-4341.
78. Zaph C, (2010) Which species are in your feces? J Clin Invest 120: 4182-4185.
79. Kuroda M, Sekizuka T, Shinya F, Takeuchi F, Kanno T, et al. (2012) Detection of a possible bioterrorism agent, Francisella sp., in a clinical specimen by ise of next-generation direct DNA sequencing. J Clin Microbiol 50: 1810-1812.
80. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, et al. (2009) Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog 5: e1000455 doi:10.1371/journal.ppat.1000455.
81. García-Álvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, et al. (2011) Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis 11: 595-603.
82. Metzgar D, (2011) Adaptive evolution of diagnostic resistance. J Clin Microbiol 49: 2774-2775.
83. Kupferschmidt K, (2011) Epidemiology. Outbreak detectives embrace the genome era. Science 333: 1818-1819.
84. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, et al. (2012) Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol 30: 434-439.
85. Eisenstein M, (2012) Oxford Nanopore announcement sets sequencing sector abuzz. Nat Biotechnol 30: 295-296.
86. Underwood A, Green J, (2011) Call for a quality standard for sequence-based assays in clinical microbiology: necessity for quality assessment of sequences used in microbial identification and typing. J Clin Microbiol 49: 23-26.
87. Palm D, Johansson K, Ozin A, Friedrich A, Grundmann H, et al. (2012) Molecular epidemiology of human pathogens: how to translate breakthroughs into public health practice, Stockholm, November 2011. Euro Surveill 17.
88. Pop M, Salzberg SL, (2008) Bioinformatics challenges of new sequencing technology. Trends Genet 24: 142-149.
89. Nusbaum C, Ohsumi TK, Gomez J, Aquadro J, Victor TC, et al. (2009) Sensitive, specific polymorphism discovery in bacteria using massively parallel sequencing. Nat Methods 6: 67-69.
90. Voelkerding KV, Dames SA, Durtschi JD, (2009) Next-generation sequencing: from basic research to diagnostics. Clin Chem 55: 641-658.
91. Green ED, Guyer MS, (2011) Institute NHGR (2011) Charting a course for genomic medicine from base pairs to bedside. Nature 470: 204-213.
92. Prosperi MC, Prosperi L, Bruselles A, Abbate I, Rozera G, et al. (2011) Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing. BMC Bioinformatics 12: 5.
93. Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, et al. (2011) Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 52Suppl 5: S397-S428.
94. Kahlmeter G, Brown DF, Goldstein FW, MacGowan AP, Mouton JW, et al. (2003) European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 52: 145-148.
95. Shafer RW, (2006) Rationale and uses of a public HIV drug-resistance database. J Infect Dis 194Suppl 1: S51-S58.
96. Knoppers BM, Harris JR, Tassé AM, Budin-Ljøsne I, Kaye J, et al. (2011) Towards a data sharing Code of Conduct for international genomic research. Genome Med 3: 46.
97. Ormsby CE, Reyes-Terán G, (2009) Influenza: making privileged data public. Science 325: 1072; author reply 1072-1073.
98. Caulfield T, Harmon SH, Joly Y, (2012) Open science versus commercialization: a modern research conflict? Genome Med 4: 17.
99. Gupta R, Michalski MH, Rijsberman FR, (2009) Can an infectious disease genomics project predict and prevent the next pandemic? PLoS Biol 7: e1000219 doi:10.1371/journal.pbio.1000219.
100. Chain P, Grafham D, Fulton R, Fitzgerald M, Hostetler J, et al. (2009) Genomics. Genome project standards in a new era of sequencing. Science 326: 236-237.
101. National Food Institute/Technical University of Denmark (2011) Perspectives of a global, real-time microbiological genomic identification system- implications for national and global detection and control of infectious diseases. Consensus report of an expert meeting 1-2 September 2011, Bruxelles, Belgium (1. edition).
102. Aanensen DM, Spratt BG, (2005) The multilocus sequence typing network: mlst.net. Nucleic Acids Res 33: W728-W733.
103. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
104. UK HIV Drug Resistance Database (2009) Annual Report 2008/09.
105. Church G, Heeney C, Hawkins N, de Vries J, Boddington P, et al. (2009) Public access to genome-wide data: five views on balancing research with privacy and protection. PLoS Genet 5: e1000665 doi:10.1371/journal.pgen.1000665.
106. Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R, et al. (2011) Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile. J Clin Microbiol 49: 2230-2238.
107. Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, et al. (2012) Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 16: 216-220.
108. Fears R, van der Meer JW, ter Meulen V, (2010) Translational medicine policy issues in infectious disease. Sci Transl Med 2: 14cm12.
109. Comas I, Chakravartti J, Small P, Galagan J, Niemann S, et al. (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42: 498-503.
110. Enright MC, Spratt BG, (2011) Genomics. The genomic view of bacterial diversification. Science 331: 407-409.
111. Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CC, et al. (2012) Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet 44: 352-355.
112. MacPherson DW, Gushulak BD, Baine WB, Bala S, Gubbins PO, et al. (2009) Population mobility, globalization, and antimicrobial drug resistance. Emerg Infect Dis 15: 1727-1732.
113. Fabre M, Hauck Y, Soler C, Koeck JL, van Ingen J, et al. (2010) Molecular characteristics of "Mycobacterium canettii" the smooth Mycobacterium tuberculosis bacilli. Infect Genet Evol 10: 1165-1173.
114. Reddington K, O'Grady J, Dorai-Raj S, Maher M, van Soolingen D, et al. (2011) Novel multiplex real-time PCR diagnostic assay for identification and differentiation of Mycobacterium tuberculosis, Mycobacterium canettii, and Mycobacterium tuberculosis complex strains. J Clin Microbiol 49: 651-657.
115. Feuerriegel S, Köser CU, Baù D, Rüsch-Gerdes S, Summers DK, et al. (2011) Impact of fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824. Antimicrob Agents Chemother 55: 5718-5722.
116. Bifani P, Kurepina N, Mathema B, Wang XM, Kreiswirth B, (2009) Genotyping of Mycobacterium tuberculosis clinical isolates using IS6110-based restriction fragment length polymorphism analysis. Methods Mol Biol 551: 173-188.
117. Driscoll JR, (2009) Spoligotyping for molecular epidemiology of the Mycobacterium tuberculosis complex. Methods Mol Biol 551: 117-128.
118. Louw G, Warren R, Gey van Pittius N, McEvoy C, Van Helden P, et al. (2009) A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother 53: 3181-3189.